Dongbao Biotech Co., Ltd.

Notice on Resumption of Conversion for Dongbao Convertible Bonds

Announcement on Participation in the 2026 Inner Mongolia Listed Companies Investor Online Reception Day

Implementation Announcement of the 2025 Annual Equity Distribution

Announcement on the Adjustment of the Conversion Price of 'Dongbao Convertible Bonds'

Notice on the suspension of conversion of 'Dongbao Convertible Bonds' during the equity distribution period

Announcement of Resolutions of the Second Meeting of the Tenth Board of Directors

Announcement from Baotou Dongbao Biotechnology Co., Ltd. Regarding Not Lowering the Conversion Price of 'Dongbao Convertible Bonds'

Reminder Announcement on the Expected Trigger of Downward Adjustment Conditions for Dongbao Convertible Bonds

Legal opinion letter from Shanghai Renying Law Firm regarding the annual general meeting of shareholders of Baotou Dongbao Biotechnology Co., Ltd. in 2025

Announcement of the resolutions of the annual general meeting of shareholders in 2025

Announcement of the resolutions of the first meeting of the 10th Board of Directors

Announcement on the completion of the board of directors' re-election and the appointment of senior management personnel

Announcement on the Election of Employee Representative Directors

Announcement of Resolutions from the 16th Meeting of the 9th Board of Directors

Q1 2026 Report

Notice of 2025 Annual Shareholders' Meeting

China Merchants Securities Co., Ltd. Summary Report on Continuous Supervision and Sponsorship of Baotou Dongbao Biotechnology Co., Ltd.'s Issuance of Convertible Corporate Bonds to Unspecified Objects

China Merchants Securities Co., Ltd. 2025 Annual On-site Inspection Report on Baotou Dongbao Biotechnology Co., Ltd.

China Merchants Securities Co., Ltd. 2025 Annual Tracking Report on Baotou Dongbao Biotechnology Co., Ltd.

Notice on Holding the Online Explanation Meeting for the 2025 Annual Report

Announcement on the conversion of convertible bonds in the first quarter of 2026 by Baotou Dongbao Biotechnology Co., Ltd.

Verification Opinion from China Merchants Securities Co., Ltd. on Baotou Dongbao Bio-Tech Co., Ltd.'s Additional Investment with Self-Owned Funds, Adjustment of Internal Investment Structure, and Extension of Investment Projects

Verification Opinion from China Merchants Securities Co., Ltd. on Baotou Dongbao Bio-Tech Co., Ltd.'s Estimated Daily Related Party Transactions for 2026

Special Verification Opinion from China Merchants Securities Co., Ltd. on Baotou Dongbao Bio-Tech Co., Ltd.'s 2025 Annual Deposit, Management, and Use of Raised Funds

Announcement on Re-appointing the 2026 Annual Audit Firm

Baotou Dongbao Bio-Tech Co., Ltd. Independent Director's 2025 Annual Performance Report (Ren Bin)

Baotou Dongbao Bio-Tech Co., Ltd. Independent Director's 2025 Annual Performance Report (Wang Jing)

Baotou Dongbao Bio-Tech Co., Ltd. Independent Director's 2025 Annual Performance Report (Erdun Taoketao)

Verification Opinion from China Merchants Securities Co., Ltd. on Baotou Dongbao Bio-Tech Co., Ltd.'s 2025 Annual Internal Control Evaluation Report

Internal Control Audit Report

Internal Control Evaluation Report

Articles of Association (March 2026)

Rules of Procedure for Board Meetings (March 2026)

Remuneration Management Measures for Directors and Senior Management (March 2026)

Shareholder Dividend Return Plan for the Next Three Years (2026-2028) (March 2026)

Working System for Independent Directors (March 2026)

Management System for Raised Funds (March 2026)

Working Rules for the Board's Remuneration and Assessment Committee (March 2026)

Code of Conduct for Information Disclosure by Controlling Shareholders, Actual Controllers, Directors, and Senior Management (March 2026)

2025 Annual Report of the Board of Directors

Announcement on the Company and its Subsidiaries Applying for Comprehensive Credit Lines from Banks and Other Financial Institutions

Announcement on Adjusting the Number of Board Members and Amending the Articles of Association

Announcement on the 2026 Annual Remuneration Plan for the Company's Directors and Senior Management

Announcement on Changes in Accounting Policies

Announcement on Accruing Asset Impairment Provisions for Fiscal Year 2025

Announcement on the Second Extension of the 2022 Employee Stock Ownership Plan's Duration

Independent Director Nominator Declaration and Commitment (Wang Jing)

Independent Director Nominator Declaration and Commitment (Erdun Taoketao)

Independent Director Candidate Declaration and Commitment (Wang Jing)

Independent Director Candidate Declaration and Commitment (Erdun Taoketao)

Announcement on Early Board of Directors Re-election

Announcement on Additional Investment with Self-Owned Funds, Adjustment of Internal Investment Structure, and Extension of Investment Projects

Verification Opinion from China Merchants Securities Co., Ltd. on Baotou Dongbao Bio-Tech Co., Ltd.'s Use of Partially Idle Raised Funds to Temporarily Supplement Working Capital

Announcement on Temporarily Supplementing Working Capital with Partially Idle Raised Funds

Announcement on the Estimated Daily Related Party Transactions for the Year 2026

Notice of Convening the 2025 Annual General Meeting of Shareholders

Resolution Announcement of the 15th Meeting of the Ninth Board of Directors

Announcement on the 2025 Annual Profit Distribution Plan

Special Report on the Annual Deposit, Management, and Use of Raised Funds for the Year 2025

2025 Annual Attestation Report on the Deposit, Management, and Use of Raised Funds

Assessment Report on the Performance of the Accounting Firm for the Year 2025 and the Audit Committee's Report on the Fulfillment of its Supervisory Responsibilities

Special Explanation of Non-Operating Fund Occupation and Other Related Fund Transactions for the Year 2025

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for the Year 2025

Special Opinion of the Board of Directors of Baotou Dongbao Bio-Tech Co., Ltd. on the Independence of Independent Directors

2025 Annual Audit Report

2025 Annual Report

2025 Annual Report Summary

Verification Opinion from China Merchants Securities Co., Ltd. on Baotou Dongbao Bio-Tech Co., Ltd.'s Use of Part of Temporarily Idle Raised Funds and Own Funds for Cash Management

Announcement on Using Part of Temporarily Idle Raised Funds and Own Funds for Cash Management